The Cooper Companies, Inc. logo
The Cooper Companies, Inc. (COO)
Compare

The Cooper Companies, Inc. (COO) Average EV/EBITDA Ratio

EV/EBITDA Ratio

The current ev/ebitda ratio for The Cooper Companies, Inc. (COO) is 17.97x as of Sunday, June 14, 2026, shown against its trailing averages.

Average EV/EBITDA Ratio Chart

COO EV/EBITDA Ratio Averages

EV/EBITDA RATIO CURRENT

17.97x

EV/EBITDA RATIO TTM

15.95x

EV/EBITDA RATIO 3Y

20.14x

EV/EBITDA RATIO 5Y

21.92x

EV/EBITDA RATIO 10Y

22.78x

EV/EBITDA RATIO 15Y

20.62x

EV/EBITDA RATIO 20Y

18.50x

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA
16,000 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert G. White